United States· US:83616-107_5a6cd8e9-9d15-d428-e063-6294a90a4dfb
Tudriqev
A medicinal product containing vusolimogene oderparepvec, registered in United States by Replimune, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- VUSOLIMOGENE ODERPAREPVEC
- Manufacturer
- Replimune, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 13, 2026
Packs & prices · 1
- ndc1183616-107-11
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bbff9d29-8ceb-4aaa-85ab-bf37e63121cf GET /v1/drugs/bbff9d29-8ceb-4aaa-85ab-bf37e63121cf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRATUMOR",
"source": "ndc",
"strength": "10000000",
"substance": "VUSOLIMOGENE ODERPAREPVEC",
"productndc": "83616-107",
"dosage_form": "INJECTION, SUSPENSION",
"dea_schedule": null,
"strength_unit": "[PFU]/mL",
"application_number": "BLA125827",
"marketing_category": "BLA"
}See everything about vusolimogene oderparepvec.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.